India has large number of scientist, engineers & bio-technologist who can play very pivotal role in taking the industry to the next level. The Indian pharmaceutical sector is the third largest in terms of volume and ranking thirteen in terms of value. There is a prominent presence of branded generics in the domestic market. Also India is responsible for developing niche portfolio of drugs for the US market. Growing with an average rate of about 20 per cent the domestic biotechnology sector comprising of different streams may reach the US$ 7 bn mark by the end of current financial year. Fleming Gulf presents “The Pharma & Drug Manufacturing Technology Summit” which is taking place on 08 -09 September, 2015 in Mumbai. The topic of discussions will be Big Data Usage For Better ROI‘s & Data Optimization, Data Management For Storage, Retrieving & Analyzing Data, Plasma Protein Therapy:Indian Scenario and many more.